Evidence-Based Pharmacotherapy for Dry Eye Disease, Part 2

Evidence-Based Pharmacotherapy for Dry Eye Disease, Part 2


Identification: MSNJ2303
Issue: January-February 2023
Volume: Vol. 32/No. 1
Credits (Post Test and/or Evaluation Required)
Available until 02/28/2025
  • 1.30 - CH
  • 0.75 - Rx


Description

AMSN members may access the article through their mailed copy as well as the emailed electronic edition. PDFs of articles will no longer be available in the online library.

Learning Outcome:
After completing this education activity, the learner will be able to discuss treatment of dry eye disease (DED) with topical corticosteroid and second-line therapies.

Contact hours available until 2/28/2025.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers, authors):

The author(s), editor, editorial committee, content reviewers, and education director reported no actual or potential conflict of interest in relation to this nursing continuing professional development article.

Commercial Support:

  • Janie Best - F. A. Davis - Author
    The textbook is published and quarterly royalty check is deposited based upon book sales (typically < $500 / quarter)
  • Kristi Campoe - TillaCare, Ltd.
    Employee
  • Amy Lipsett - Mitigate Risk Management
    Consultant
  • Amy Lucas - Lippincott/Wolters Kluwer
    Clinical content reviewer for nursing procedures
  • Garrett Mitchell - Elsevier
    Author of 3 chapters in book
  • Kristi Reguin-Hartman -
    Philips - Employee
    Relias - Employee
  • Mary Schreiber (Ed Board) - South Carolina Technical College System - Nursing Education Consultant  
    Contract ends March 31, 2023
  • Paula Wyman - HCA Healthcare - Stocks

Accreditation Statement:
This education activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.

This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, AMSN Education Director.

Author(s):

Tags

Assessment Medication Management Pharmacology Education of Patients and Families Established Evidence-Based Practice and Research dry eye disease dry eye syndrome keratoconjunctivitis sicca ocular disorder vision tear film artificial tears tear stimulants

Credits Available


Evidence-Based Pharmacotherapy for Dry Eye Disease, Part 2

You must be logged in and own this product in order to post comments.

Kelli Nichols
3/8/23 9:04 am

Very educational and informative

Jasmin Villaflor
3/8/23 12:21 pm

very educational and informative

Danielle Joslin
3/16/23 8:12 pm

good information

Mandy Bewkes
4/14/23 1:54 am

Most of the population group i care for are the elderly. We work very closely with our pharmacist and providers to ensure needs are met. This condition can be very painful.

Maria Libano
5/3/23 7:31 pm

This article is very informative.

Mayette Miranda
5/11/23 6:04 am

Very informative.

Jayne Alviola
9/3/23 2:07 am

Excellent article.

Moira Howell
10/29/23 4:05 pm

This article is a helpful reminder about correctly administering eye drops to patient's that wear contacts and the type of drop the patient is taking. I personally have tried two of these medications and the drops have been successful in treating my own dry eye disease.

References